ALX Oncology: Piper Sandler Keeps Overweight Rating, PT Raised to $4

Thursday, Feb 5, 2026 11:03 am ET1min read
ALXO--

ALX Oncology: Piper Sandler Keeps Overweight Rating, PT Raised to $4

ALX Oncology: Piper Sandler Keeps Overweight Rating, PT Raised to $4

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet